Testing effectiveness (Phase 2)Ended earlyNCT00085410
What this trial is testing
Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder
Who this might be right for
Adenocarcinoma of the Extrahepatic Bile DuctAdenocarcinoma of the GallbladderAdvanced Adult Primary Liver Cancer+7 more
National Cancer Institute (NCI) 20